Who
Albert G. White III
Director
Company insider
Files Form 4 as: Director, Evolus; President & CEO, The Cooper Companies.
In numbers
- Trades disclosed
- 210
- Buys
- 11
- Sells
- 10
- Bought
- $2.1M
- Sold
- $59.2M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 10 Apr 2006
- Last trade
- 17 Feb 2026
- Last filed
- 19 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Feb 2026filed 19 Feb 2026 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —45,559 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —45,559 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code M | —18,340 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code F | $783K9,419 at $83.13 | filing |
| 8 Jan 2026filed 12 Jan 2026 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code M | —18,340 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code M | —18,340 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code M | —18,340 at $0.00 | filing |
| 8 Jan 2026filed 12 Jan 2026 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code F | $783K9,419 at $83.13 | filing |
| 16 Dec 2025filed 16 Dec 2025 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Bought | $808K10,000 at $80.80 | filing |
| 9 Dec 2025filed 11 Dec 2025 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —42,306 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code A | —84,613 at $0.00 | filing |
| 5 Sep 2025filed 5 Sep 2025 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Bought | $684K10,000 at $68.39 | filing |
| 9 Jun 2025filed 10 Jun 2025 | EOLS EvolusBiotechnology | SEC FORM 4 Bought | $189K20,000 at $9.45 | filing |
| 7 Mar 2025filed 11 Mar 2025 | EOLS Evolusoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,146 at $0.00 | filing |
| 7 Mar 2025filed 11 Mar 2025 | EOLS EvolusBiotechnology | SEC FORM 4 Code A | —7,364 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code M | —84,264 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code M | —84,264 at $0.00 | filing |
| 1 Feb 2025filed 4 Feb 2025 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code F | $4.1M42,790 at $96.55 | filing |
| 8 Jan 2025filed 10 Jan 2025 | COO The Cooper Companiesoption or derivative · Medical Devices | SEC FORM 4 Code M | —18,340 at $0.00 | filing |
| 8 Jan 2025filed 10 Jan 2025 | COO The Cooper CompaniesMedical Devices | SEC FORM 4 Code M | —18,340 at $0.00 | filing |
News
Rosen Law Firm Continues Securities Probe Into Cooper CompaniesCOO · econotimes.com · 18 Oct 2026Cooper Companies (NASDAQ:COO) versus QuidelOrtho (NASDAQ:QDEL) Critical ContrastCOO · dailypolitical.com · 11 Oct 2026Cooper Companies Director Kurzius Buys 10,000 Shares for $539,100. What Does This Insider See in Shares?COO · fool.com · 7 Oct 2026
0 headlines in the last 90 days name Albert G. White III; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.